Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products
浙江東方基因生物的部門獲得美國食品藥品管理局批准註冊兩款產品
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊